The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation

Peter Jackson, Trishul Siddharthan

Source: Eur Respir J, 55 (4) 2000184; 10.1183/13993003.00184-2020
Journal Issue: April
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Peter Jackson, Trishul Siddharthan. The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation. Eur Respir J, 55 (4) 2000184; 10.1183/13993003.00184-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review
Source: Eur Respir J 2014; 43: 1763-1775
Year: 2014



Chronic respiratory diseases (CRDs) in low- and middle-income countries (LMICs): A scoping review of survey methodologies
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020


Evidence-implementation gaps in low- and middle-income countries' COPD guidelines
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020


Chronic obstructive pulmonary disease (COPD) prevalence surveys in low- and middle-income countries (LMICs): A systematic scoping review of methodologies
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Latent tuberculosis infection in healthcare workers in low- and middle-income countries: an updated systematic review
Source: Eur Respir J, 53 (4) 1801789; 10.1183/13993003.01789-2018
Year: 2019



Newborn lung diseases in low- and middle-income countries
Source: Eur Respir Monogr 2021; 92: 343-349
Year: 2021


Health status burden of COPD - comparison across different countries and treatment settings
Source: Eur Respir J 2005; 26: Suppl. 49, 56s
Year: 2005

Towards the elimination of paediatric tuberculosis in high-income, immigrant-receiving countries: a 25-year conventional and molecular epidemiological case study
Source: ERJ Open Res, 4 (2) 00131-2017; 10.1183/23120541.00131-2017
Year: 2018



Pragmatic tuberculosis prevention policies for primary care in low- and middle-income countries
Source: Eur Respir J, 51 (3) 1800315; 10.1183/13993003.00315-2018
Year: 2018



Practical challenges and solutions to TB control in a lower–middle-income country: experiences from Mongolia
Source: Breathe, 14 (3) 180; 10.1183/20734735.020218
Year: 2018



The social and structural determinants of tuberculosis incidence trends in 116 countries from 2005-2015: an ecological study
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021


Impact of clinical and socio-economic factors on tuberculosis transmission rate in European cities: meta-analysis of molecular epidemiological studies
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009

The economic burden of uncontrolled asthma across Europe and the Asia-Pacific region: can we afford to not control asthma?
Source: Eur Respir Rev 2006; 15: 1-3
Year: 2006


Collating data from major European population studies – The CADSET (Chronic airway disease early stratification) clinical research collaboration
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020




Widespread use of serological tests for tuberculosis: data from 22 high-burden countries
Source: Eur Respir J 2012; 39: 502-505
Year: 2012


Medical and social characteristics of families and infection sources for migrants from high-burden countries
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008